Europe News and Press release service
About Us | Contact Us

Europe News Headlines and Press Release Distribution

Home | Europe News | Press Release Distribution
Unlimited Press Release Distribution

Press release distribution service

News Media

Corriere della Sera
Financial Times
De Telegraaf
Daily Mail
Daily & Sunday Expresss
Daily Star
Kronen Zeitung
Le Figaro
Le Monde
Le Parisien
Moskovskij Komsomolets
Ouest France
Yahoo Europe

Europe News and Press Release Distribution

Europe Multiple Myeloma Therapeutics Market estimated to be growing at a CAGR of 4.58%, to reach $2.25 billion by 2021


(EuropeNewsWire.Net, February 13, 2017 ) Europe Multiple Myeloma Therapeutics Market is projected to reach USD 2.25 Billion by 2021, at a CAGR of 4.58% from 2016 to 2021.

For full report refer to””

Free sample for the report is available at””

The Multiple Myeloma (MM) market is presently dominated by Velcade and Revlimid, and the market is set to experience considerable growth between 2016 and 2021. As multiple myeloma is mostly irredeemable and is regularly characterised by a cycle of reduction and relapse, there is an acute need for new treatments for patients that work in distinctive and innovative ways.

Improved investments in R&D in the pharmaceutical area, absence of healing drugs for blood diseases and the introduction of advanced drugs have fuelled the growth of multiple myeloma therapeutics market. Therapies such as radiation therapy, chemotherapy, physiotherapy, and biological therapy have huge potential to outgrowth the market.

Enquire more about the report at””


By Treatment Type:
• Chemotherapy
 Anthracycline antibiotic
 Melphalan (Alkeran)
 Liposomal doxorubicin (Doxil)
 Alkylating agent
 Doxorubicin (Adriamycin)
 Cyclophosphamide (Neosar)
 Vincristine (Oncovin)
 Carmustine (BiCNU)

• Targeted therapy
 Proteasome inhibitor
 Bortezomib (Velcade)
 Carfilzomib (Kyprolis)

By Drug Type
• Corticosteroids
 Dexamethasone (Decadron)
 Prednisone (Deltasone/Orasone)
• Immunomodulatory agents
 Thalidomide (Thalomid)
 Lenalidomide (Revlimid)
 Arsenic trioxide (Trisenox)
 Plerixafor (Mozobil)

By Region
• U.K
• Spain
• Germany
• Italy
• France

Some of the key contributors in the industry include AB Science SA, AbbVie Inc., Ablynx NV, Acceleron Pharma Inc., IGF Oncology LLC. , ImmunGene Inc., Millennium Pharmaceuticals Inc., MimiVax LLC, Mirna Therapeutics, RedHill Biopharma Ltd., Rhizen Pharmaceuticals S.A., Terpenoid Therapeutics Inc. ,Teva Pharmaceutical Industries Ltd. ,TG Therapeutics Inc. and Johnson and Johnson.

Buy now””

The Europe Multiple Myeloma Therapeutics Market Study covers:

• Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail

• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development

• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment

• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

• Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Checkout other related studies in the Therapeutics Segment:

Europe Radiotherapy Market:

Europe Autoimmune Monoclonal Antibodies Market:

Europe Monoclonal Antibodies:

Europe Neurotherapeutics Market:

Europe Immunotherapy Drugs Market:

About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Market Data Forecast


+1-888- 702-9626

Source: EmailWire.Com
Europe News by Regions
  • Austria
  • Britain
  • Czech & Slovakia
  • Denmark
  • Eastern Europe
  • France
  • Finland
  • Germany
  • Greece
  • Hungary
  • Italy
  • London
  • Poland
  • Portugal
  • The Netherlands
  • Turkey
  • Russia
  • Spain


    Europe Resource Center
    We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:

    Point of Beginning
    Overall Labor Effectiveness (OLE) Achieving a Highly Effective Workforce

    No credit cards, coupons, or promo codes required. Try it today!

    Press release service is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

    For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at
    Copyright 2008 GroupWeb Media LLC
    GroupWeb Media Network

    Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | | iT-NewsWire.Com
    | i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net ™ - Newswire and Press Release service of GroupWeb Media LLC